| 141 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Differentiation of Langerhans cells in Langerhans cell histiocytosis/
|
Geissmann, F
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 142 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation/
|
Cwynarski, K
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 143 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age/
|
Kollman, C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 144 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia/
|
Dazzi, F
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 145 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia/
|
Olavarria, E
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 146 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification/
|
Miguel, J F San
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 147 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting/
|
Rahimy, M C
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 148 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: The US National Marrow Donor Program Experience/
|
Petersdorf, E W
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 149 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation/
|
Belhassen, L
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 150 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Engraftment and survival after unrelated-donor bone marrow transplantation: A report from the National Marrow Donor Program/
|
Davies, S M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 151 |
|
CLINICAL OBSERVATIONS INTERVENTIONS, AND THERAPEUTIC TRIALS - Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT/
|
Esser, J W J van
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 152 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia/
|
Mesa, R A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 153 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Evolving characteristics of AIDS-related lymphoma/
|
Levine, A M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 154 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation/
|
Rowley, S D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 155 |
|
CLINICAL OBSERVATIONS INTERVENTIONS, AND THERAPEUTIC TRIALS - Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma/
|
Lossos, I S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 156 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma/
|
Weng, W-K
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 157 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study/
|
Greinix, H T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 158 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Extracorporeal photopheresis in S�zary syndrome: Hematologic parameters as predictors of response/
|
Evans, A V
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 159 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer/
|
McNiece, I
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 160 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Ex vivo expanded unselected peripheral blood: Progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer/
|
Paquette, R L
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
기사
(465)
